Announcements Trials
Browse Landscape

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Other 2Genitourinary 2Thoracic 1Lymphoid 1Head & Neck 1Classical hematology 1CNS 1

Conditions

Lung Neoplasms 1370Carcinoma, Non-Small-Cell Lung 1080Breast Neoplasms 183Neoplasms 145Small Cell Lung Carcinoma 137Colorectal Neoplasms 104Adenocarcinoma of Lung 86Melanoma 84Prostatic Neoplasms 80Pancreatic Neoplasms 79Esophageal Neoplasms 70Head and Neck Neoplasms 69Ovarian Neoplasms 67Colonic Neoplasms 67Stomach Neoplasms 63Urinary Bladder Neoplasms 49Neoplasm Metastasis 49Disease 49Mesothelioma 44Liver Neoplasms 44Pulmonary Disease, Chronic Obstructive 42Mesothelioma, Malignant 42Brain Neoplasms 37Lung Diseases 36Carcinoma, Renal Cell 35Uterine Cervical Neoplasms 34Pleural Effusion, Malignant 34Kidney Neoplasms 33NSCLC 31Carcinoma 28

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Observational × Ischemic Stroke × Thoracic × Clear all
NCT03987633 2025-03-10

EMPOWER

Future Genetics Limited

Recruiting
200,000 enrolled
GenitourinaryOtherThoracic

Ischemic Stroke, Arthritis, Rheumatoid, Asthma, Atrial Fibrillation, Mental Disorders, Cardiovascular Diseases, Coronary Disease, Dementia, Depression, Diabetes Mellitus, Epilepsy, Heart Failure, Hypertension, Lung Neoplasms, Neoplasms, Obesity, Prostatic Neoplasms, Pulmonary Disease, Chronic Obstructive, Renal Insufficiency, Chronic, Peripheral Arterial Disease

Data powered by HemOnc (CC BY 4.0) Colophon âš¡